Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

146.28 -1.12 (-0.76%)
Official Closing Price Updated: 7:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,591,484
Open 147.31
Bid (Size) 146.30 (1)
Ask (Size) 146.66 (1)
Prev. Close 147.40
Today's Range 146.01 - 147.68
52wk Range 133.05 - 175.91
Shares Outstanding N/A
Dividend Yield 3.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Dividend Stocks to Buy Now or You’ll Be Kicking Yourself Later
Dividend stocks are a hedge against volatile markets. Here are seven dividend stocks that you should buy now before you regret missing out. 
Via InvestorPlace
2 of the Best Dividend Stocks to Own in 2023
You can count on them for passive income and growth over time. 
Via The Motley Fool

Performance

YTD
-9.92%
-9.92%
1 Month
-10.01%
-10.01%
3 Month
-0.08%
-0.08%
6 Month
+4.32%
+4.32%
1 Year
+6.06%
+6.06%

More News

Read More
5 Cheapest Health Care Stocks You Should Think About
Via Benzinga
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
Via InvestorPlace
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
3 Reasons to Buy AbbVie and 2 Reasons Not to Buy
Via The Motley Fool
2 Top Passive-Income Stocks to Own in 2023
Via The Motley Fool
AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.
Via The Motley Fool
Want Safety and Growth in 2023? Try These Dividend Stocks.
Via The Motley Fool
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Via MarketBeat
Charles River Laboratories, AbbVie, Star Bulk Carriers And This Big Bank Are CNBC's 'Final Trades'
Via Benzinga
7 Stocks Every Smart Investor Should Own in 2023
Via InvestorPlace
3 Unstoppable Stocks to Keep Buying in 2023
Via The Motley Fool
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
7 Biotech Stocks That Will Make You Rich in 10 Years
Via InvestorPlace
2 Cheap Growth Stocks That Can Set You Up for Life
Via The Motley Fool
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Via Talk Markets
Could This FDA Approval Boost AbbVie's Stock?
Via The Motley Fool
With Competition on the Rise, Is AbbVie's Dividend Safe?
Via The Motley Fool
AbbVie, Eli Lilly Leave UK's Voluntary Medicines Pricing Agreement Over Increasing Prices
Via Benzinga
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
Via The Motley Fool
Is AbbVie a Good Dividend Stock to Buy on the Dip?
Via The Motley Fool
4 High-Yield Dividend Kings For 2023
Via MarketBeat
5 Dividend Kings I Bought for My Portfolio
Via The Motley Fool
Top-Performing Hedge Fund In 2022 Has This Strategy To Thank: How Much Did It Make Last Year?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.